Audeara’s Wholesale Revenue Hits $1.75m YTD, Matching Full FY25
Audeara Limited has secured its largest-ever Australian wholesale purchase order worth $560,000, driving year-to-date wholesale revenues to $1.75 million and matching full FY25 figures. The company is also expanding manufacturing into China, signaling growing international ambitions.
- Record $560,000 purchase order from largest Australian wholesale customer
- FY26 wholesale revenue hits $1.75 million, up 50% year-on-year
- Manufacturing of hearing aids commenced for Chinese market under licensing deal
- AUA Technology division advancing global orders and partnerships
- Ongoing discussions for new distribution and licensing agreements worldwide
Record Wholesale Order Signals Domestic Strength
Audeara Limited (ASX – AUA) has announced a milestone $560,000 purchase order from its largest Australian wholesale customer, marking the company’s biggest single order to date. This order, expected to be delivered and recognised in the March quarter of FY26, pushes the year-to-date Australian wholesale revenue to approximately $1.75 million. This figure represents a 50% increase compared to the prior year period and matches the entire FY25 wholesale revenue, underscoring Audeara’s growing footprint in its home market.
Momentum in AUA Technology Division
Beyond wholesale sales, Audeara’s AUA Technology division continues to gain traction globally. The company is progressing with the second and final shipment under a major purchase order from a global music industry leader, with revenues from this expected to be recognised in the current quarter. These developments highlight the increasing contribution of the technology division to Audeara’s overall financial performance and its strategic pivot towards licensing proprietary hearing technology to large commercial partners.
Expanding Manufacturing and Market Reach in China
In a significant step towards international expansion, Audeara has commenced manufacturing hearing aids in China through a licensing agreement with Eastech (Huizhou) Co., Ltd. These products, manufactured under Eastech’s National Medical Products Administration certification, will be sold under a third-party brand and distributed via a leading Chinese e-commerce platform. This move opens a substantial new addressable market for Audeara’s technology and signals the company’s ambitions to establish a global presence beyond its Australian base.
Looking Ahead – Partnerships and Growth Opportunities
Audeara is actively engaged in advanced discussions with multiple distribution and licensing partners across domestic and international markets. The company’s leadership emphasizes the importance of these partnerships in driving multi-channel growth and consistent revenue streams. Managing Director Dr James Fielding highlighted the company’s positioning as a leading hearing technology provider, with further updates expected soon that could shed light on new commercial agreements and market expansions.
Bottom Line?
Audeara’s record order and international manufacturing launch set the stage for accelerated growth and global market penetration in FY26.
Questions in the middle?
- Will the momentum in AUA Technology translate into sustained global revenue growth?
- How will the Chinese manufacturing partnership impact Audeara’s margins and brand positioning?
- What are the timelines and potential scale of the new distribution and licensing agreements?
